Subarachnoid Hemorrhage Reduces Retinal Ganglion Cells, Increases New Vessel Development
Using animal models, researchers determine subarachnoid hemorrhage can lead to new vessel development and the reduction of ganglion cells.
Anti-VEGF Drugs
Anti-VEGF Injections May Reduce Glaucoma Burden for Some
Study shows reductions in intraocular pressures and antiglaucoma medication use.
Wearing Surgical Masks, Talking During Ophthalmic Procedure May Spread Bacteria
Investigators explored the impact patient-worn face masks have on bacterial spread during ophthalmic procedures and offered solutions to prevent contamination.
Systemic Ang2 Upregulation Represents Potential Treatment Target for nAMD
Researchers consider the potential for Ang2 as a target for antiangiogenic agents in treatment of the disease.
Pandemic Associated With Reduced Intravitreal Injections in France
Across France, fewer patients than expected underwent anti-VEGF treatments during COVID-19 lockdowns.
Ranibizumab Effective, Safe Long-Term Treatment for Diabetic Macular Edema, Study Says
The multicenter study confirms improvements in acuity and central retinal thickness.
Top Retina Highlights From the American Academy of Ophthalmology 2020 Conference
Researchers shared their latest retinal findings at the virtual conference.
Investigators: Ranibizumab Port Delivery System Durable, Effective
Study shows the time release device is comparable to monthly ranibizumab 0.5 mg injections.
Research Compares Imaging Technologies for Age-Related Macular Degeneration Monitoring
A study shows SD-OCT is appropriate in most cases.
Consistent Injections Better Maintain Visual Acuity, Study Says
Research shows how patients with AMD who are lost to follow-up face worse vision in time.
-
Loading...
-
Loading...
Next post in Retina & Vitreous
